AbstractSuccessful immunisation programmes generally result from high vaccine effectiveness and adequate uptake of vaccines. In the development of new vaccination strategies, the structure and strength of the local healthcare system is a key consideration. In high income countries, existing infrastructures are usually used, while in less developed countries, the capacity for introducing new vaccines may need to be strengthened, particularly for vaccines administered beyond early childhood, such as the measles or human papillomavirus (HPV) vaccine. Reliable immunisation service funding is another important factor and low income countries often need external supplementary sources of finance. Many regions also obtain support in generating an e...
AbstractNew vaccines have been demonstrated to be effective in reducing morbidity and mortality, par...
AbstractFew medical interventions compete with vaccines for their cumulative impact on health and we...
Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the ...
Successful immunisation programmes generally result from high vaccine effectiveness and adequate upt...
AbstractSuccessful immunisation programmes generally result from high vaccine effectiveness and adeq...
OBJECTIVE: To synthesise lessons learnt and determinants of success from human papillomavirus (HPV) ...
Demonstration projects or pilots of new public health interventions aim to build learning and capaci...
AbstractLow-income countries typically lag behind industrialised nations, where the introduction of ...
IntroductionPan American Health Organization\u2019s (PAHO) ProVac Initiative aims to strengthen coun...
BACKGROUND: Through a combination of strong routine immunization (RI), strategic supplemental immuni...
AbstractThe Expanded Programme on Immunization (EPI) was established in 1974 to ensure that children...
Abstract Background Globally, immunization services have been the center of renewed interest with in...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination has been slow in low-income and m...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination has been slow in low-income and m...
At national and aggregate levels, COVID-19 vaccination across G7 countries appears successful. To da...
AbstractNew vaccines have been demonstrated to be effective in reducing morbidity and mortality, par...
AbstractFew medical interventions compete with vaccines for their cumulative impact on health and we...
Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the ...
Successful immunisation programmes generally result from high vaccine effectiveness and adequate upt...
AbstractSuccessful immunisation programmes generally result from high vaccine effectiveness and adeq...
OBJECTIVE: To synthesise lessons learnt and determinants of success from human papillomavirus (HPV) ...
Demonstration projects or pilots of new public health interventions aim to build learning and capaci...
AbstractLow-income countries typically lag behind industrialised nations, where the introduction of ...
IntroductionPan American Health Organization\u2019s (PAHO) ProVac Initiative aims to strengthen coun...
BACKGROUND: Through a combination of strong routine immunization (RI), strategic supplemental immuni...
AbstractThe Expanded Programme on Immunization (EPI) was established in 1974 to ensure that children...
Abstract Background Globally, immunization services have been the center of renewed interest with in...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination has been slow in low-income and m...
BACKGROUND: Introduction of human papillomavirus (HPV) vaccination has been slow in low-income and m...
At national and aggregate levels, COVID-19 vaccination across G7 countries appears successful. To da...
AbstractNew vaccines have been demonstrated to be effective in reducing morbidity and mortality, par...
AbstractFew medical interventions compete with vaccines for their cumulative impact on health and we...
Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the ...